Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faiza Ibrahim

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Eye (London, England)|July 6, 2026
Bilateral persistent pupillary membrane causing secondary angle closure glaucoma with high myopiaRajendrababu Sharmila, Faiza Ibrahim, Nishwath Balakrishnan
Journal of Drug Assessment|March 5, 2020
Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendationsBeatriz Canibaño, Dirk Deleu, Boulenouar Mesraoua, et al.
Case Reports in Women'S Health|December 24, 2019
Severe rebound disease activity after fingolimod withdrawal in a pregnant woman with multiple sclerosis managed with rituximab: A case studyBeatriz Canibaño, Musab Ali, Boulenouar Mesraoua, et al.
Journal of Drug Assessment|October 25, 2021
Real-world experience of ocrelizumab in multiple sclerosis in an Arab populationBeatriz Garcia-Cañibano, Sami Ouanes, Gowrii Saswathy Ganesan, et al.
Orthopedic Research and Reviews|November 18, 2024
Prevalence and Risk Factors of Hip Fracture at Tertiary Hospital in Mogadishu, SomaliaAbdirazak Ahmed Adan, Mohamed Abdullahi Awale, Hassan Salad Ibrahim, et al.
Current Medical Research and Opinion|November 29, 2016
Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from QatarDirk Deleu, Boulenouar Mesraoua, Hisham El Khider, et al.
Current Medical Research and Opinion|May 17, 2018
Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overviewDirk Deleu, Boulenouar Mesraoua, Beatriz Canibaño, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2012
Prevalence, demographics and clinical characteristics of multiple sclerosis in QatarDirk Deleu, Danial Mir, Ahmed Al Tabouki, et al.
Therapeutic Advances in Neurological Disorders|November 2, 2023
Corneal immune cells as a biomarker of inflammation in multiple sclerosis: a longitudinal studyIoannis N Petropoulos, Karen John, Fatima Al-Shibani, et al.
Therapeutic Advances in Neurological Disorders|February 13, 2023
Corneal axonal loss as an imaging biomarker of neurodegeneration in multiple sclerosis: a longitudinal studyIoannis N Petropoulos, Fatima Al-Shibani, Gulfidan Bitirgen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Eye (London, England)|July 6, 2026
Bilateral persistent pupillary membrane causing secondary angle closure glaucoma with high myopiaRajendrababu Sharmila, Faiza Ibrahim, Nishwath Balakrishnan
Journal of Drug Assessment|March 5, 2020
Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendationsBeatriz Canibaño, Dirk Deleu, Boulenouar Mesraoua, et al.
Case Reports in Women'S Health|December 24, 2019
Severe rebound disease activity after fingolimod withdrawal in a pregnant woman with multiple sclerosis managed with rituximab: A case studyBeatriz Canibaño, Musab Ali, Boulenouar Mesraoua, et al.
Journal of Drug Assessment|October 25, 2021
Real-world experience of ocrelizumab in multiple sclerosis in an Arab populationBeatriz Garcia-Cañibano, Sami Ouanes, Gowrii Saswathy Ganesan, et al.
Orthopedic Research and Reviews|November 18, 2024
Prevalence and Risk Factors of Hip Fracture at Tertiary Hospital in Mogadishu, SomaliaAbdirazak Ahmed Adan, Mohamed Abdullahi Awale, Hassan Salad Ibrahim, et al.
Current Medical Research and Opinion|November 29, 2016
Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from QatarDirk Deleu, Boulenouar Mesraoua, Hisham El Khider, et al.
Current Medical Research and Opinion|May 17, 2018
Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overviewDirk Deleu, Boulenouar Mesraoua, Beatriz Canibaño, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2012
Prevalence, demographics and clinical characteristics of multiple sclerosis in QatarDirk Deleu, Danial Mir, Ahmed Al Tabouki, et al.
Therapeutic Advances in Neurological Disorders|November 2, 2023
Corneal immune cells as a biomarker of inflammation in multiple sclerosis: a longitudinal studyIoannis N Petropoulos, Karen John, Fatima Al-Shibani, et al.
Therapeutic Advances in Neurological Disorders|February 13, 2023
Corneal axonal loss as an imaging biomarker of neurodegeneration in multiple sclerosis: a longitudinal studyIoannis N Petropoulos, Fatima Al-Shibani, Gulfidan Bitirgen, et al.
Pageof 1